Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2025, Vol. 30 ›› Issue (1): 118-124.doi: 10.12092/j.issn.1009-2501.2025.01.014

Previous Articles     Next Articles

Research progress in the study of melatonin in the treatment of sepsis

LI Nan1, TANG Wanchun2, ZHANG Zhongqi1, ZUO Xiangrong1   

  1. 1 First Clinical School of Nanjing Medical University, Nanjing 210009, Jiangsu, China; 2 Department of Critical Care Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210009, Jiangsu, China
  • Received:2024-02-28 Revised:2024-05-16 Online:2025-01-26 Published:2025-01-02

Abstract:

Sepsis poses a significant threat to human health due to its widespread prevalence, high mortality rate, substantial treatment costs, and the absence of effective life-saving therapies. Melatonin, a primary hormone regulating the circadian rhythm, has demonstrated potential as a promising therapeutic agent against sepsis. Its anti-inflammatory, antioxidant, immunomodulatory, mitochondrial protective, and multi-organ protective effects are noteworthy. In this review, we summarize current research on the mechanisms of action and clinical efficacy of melatonin in sepsis treatment and multi-organ function preservation, aiming to offer new perspectives and support for sepsis research and therapy.

Key words: sepsis, melatonin, multiple organ dysfunction syndrome, organ protection

CLC Number: